tafamidis meglumine
Drug ingredientCAS 951395-08-7
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
13 FDA-registered drug labelers
Why It Matters
Appears in 1 drug and cosmetic product listings (FDA).
- •Vyndaqel
- to be discontinued
Tafamidis Meglumine Capsule
Shortage listed since September 29, 2025
Chemical Identity
Data Sources
- PubChem · compound 24970412Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA Drug ShortagesRetrieved 2026-10-04
Brief citations
tafamidis meglumine (CAS 951395-08-7) https://chemicalindependence.com/chemical/951395-08-7/ PubChem: 24970412. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/24970412 FDA National Drug Code directory: CAS 951395-08-7. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 951395-08-7. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/